Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 63Anemia, Refractory, with Excess of Blasts 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia, Myeloid, Acute 58Leukemia 50Leukemia, Lymphocytic, Chronic, B-Cell 41Multiple Myeloma 40Leukemia, Myelomonocytic, Chronic 38Lymphoma 37Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 36Myeloproliferative Disorders 34Hodgkin Disease 34Leukemia, Myeloid, Accelerated Phase 32Lymphoma, Follicular 31Anemia, Refractory 30Primary Myelofibrosis 29Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma, B-Cell, Marginal Zone 24Congenital Abnormalities 24Anemia, Aplastic 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, Large B-Cell, Diffuse 22Lymphoma, Large-Cell, Immunoblastic 21Neoplasms, Plasma Cell 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Blast Crisis 20

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Cyclophosphamide × Classical hematology × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡